Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

The relationship between clinical signs and microbiological species, spa type, and antimicrobial resistance in bovine mastitis cases in Austria.

Schabauer A, Pinior B, Gruber CM, Firth CL, Käsbohrer A, Wagner M, Rychli K, Obritzhauser W.

Vet Microbiol. 2018 Dec;227:52-60. doi: 10.1016/j.vetmic.2018.10.024. Epub 2018 Oct 28.

PMID:
30473352
2.

Enteric coating of fenoprofen calcium reduces gastrointestinal microbleeding.

Ryan JR, Riley WA, Vargas R, Offen WW, Gruber CM.

Clin Pharmacol Ther. 1987 Jul;42(1):28-32.

PMID:
3496186
3.

Dose response to fenoprofen calcium using placebo and codeine as controls.

Offen WW, Gruber CM Jr.

J Med. 1985;16(4):439-52.

PMID:
3913726
4.
5.

Comparison of fenoprofen calcium, ibuprofen and placebo in primary dysmenorrhea.

Arnold JD, Iber FL, Burt RA, Gruber CM Jr.

J Med. 1983;14(5-6):337-50.

PMID:
6366104
6.
7.

Codeine and propoxyphene in postepisiotomy pain. A two-dose evaluation.

Gruber CM Jr.

JAMA. 1977 Jun 20;237(25):2734-5.

PMID:
325238
8.

A multicenter analgesic study using single doses of placebo, propoxyphene and acetaminophen.

Gruber CM Jr, Baptisti A Jr, Bauer RO, Jain A, Lash AF, McMahon FG.

J Med. 1977;8(1):35-51.

PMID:
327003
9.
10.
11.

Analgesia, plasma levels, and dosage of propoxyphene.

Waife SO, Gruber CM Jr, Rodda BE, Nash JF.

Int J Clin Pharmacol Biopharm. 1976 Apr;13(3):177-81.

PMID:
950259
12.

Clinical pharmacology of fenoprofen: a review.

Gruber CM Jr.

J Rheumatol. 1976;2:8-17.

PMID:
781236
13.

Problems and solutions to single-dose testing of analgesics: comparison of propoxyphene, codeine, and fenoprofen.

Waife SO, Gruber CM Jr, Rodda BE, Nash JF.

Int J Clin Pharmacol Biopharm. 1975 Jul;12(1-2):301-4.

PMID:
1165140
14.

Determination of propoxyphene and norpropoxyphene by chemical ionization mass fragmentography.

Wolen RL, Ziege EA, Gruber CM Jr.

Clin Pharmacol Ther. 1975 Jan;17(1):15-20.

PMID:
1122667
15.

Clinical pharmacology.

Chernish SM, Gruber CM Jr.

J Med. 1975;6(5-6):459-62. No abstract available.

PMID:
1062485
16.

Interactions in rats between the nonsteroidal antiinflammatory drugs, aspirin and fenoprofen.

Warrick P, Rubin A, Gruber CM.

Proc Soc Exp Biol Med. 1974 Dec;147(3):599-607. No abstract available.

PMID:
4445145
17.

A pharmacokinetic interaction in man between phenobarbitone and fenoprofen, a new anti-inflammatory agent.

Helleberg L, Rubin A, Wolen RL, Rodda BE, Ridolfo AS, Gruber CM Jr.

Br J Clin Pharmacol. 1974 Oct;1(5):371-4.

18.

Problems associated with bioavailability and dosage regiment studies in man.

Wolen RL, Rubin A, Rodda BE, Ridolfo AS, Gruber CM Jr.

J Pharmacokinet Biopharm. 1974 Aug;2(4):365-77. No abstract available.

PMID:
4449010
19.

Antipyresis with fenoprofen.

Gruber CM Jr.

J Clin Pharmacol. 1974 Apr;14(4):215-8. No abstract available.

PMID:
4595987
20.

A profile of the physiological disposition and gastro-intestinal effects of fenoprofen in man.

Rubin A, Chernish SM, Crabtree R, Gruber CM, Helleberg L, Rodda BE, Warrick P, Wolen RL, Ridolfo AS.

Curr Med Res Opin. 1974;2(9):529-44. No abstract available.

PMID:
4615886
21.

Evaluation of propoxyphene napsylate compound in post partum uterine cramping.

Bauer RO, Baptisti A Jr, Gruber CM Jr.

J Med. 1974;5(6):317-28. No abstract available.

PMID:
4606533
22.

Interactions of aspirin with nonsteroidal antiinflammatory drugs in man.

Rubin A, Rodda BE, Warrick P, Gruber CM Jr, Ridolfo AS.

Arthritis Rheum. 1973 Sep-Oct;16(5):635-45. No abstract available.

PMID:
4582611
23.

Screening rapidly acting anti-inflammatory agents in patients with rheumatoid arthritis.

Ridolfo AS, Mikulaschek WM, Gruber CM Jr, Scholz NE.

Am J Med Sci. 1973 May;265(5):375-9. No abstract available.

PMID:
4576758
24.

Effects of fenoprofen and aspirin on gastrointestinal microbleeding in man.

Ridolfo AS, Rubin A, Crabtree RE, Gruber CM Jr.

Clin Pharmacol Ther. 1973 Mar-Apr;14(2):226-30. No abstract available.

PMID:
4540451
25.

Physiological disposition of fenoprofen in man. 3. Metabolism and protein binding of fenoprofen.

Rubin A, Warrick P, Wolen RL, Chernish SM, Ridolfo AS, Gruber CM Jr.

J Pharmacol Exp Ther. 1972 Nov;183(2):449-57. No abstract available.

PMID:
5083556
26.

Effectiveness of propoxyphene (Darvon).

Gruber CM Jr.

N Engl J Med. 1972 May 25;286(21):1158-9. No abstract available.

PMID:
5019648
27.

Physiological disposition of fenoprofen in man. II. Plasma and urine pharmacokinetics after oral and intravenous administration.

Rubin A, Rodda BE, Warrick P, Ridolfo AS, Gruber CM Jr.

J Pharm Sci. 1972 May;61(5):739-45. No abstract available.

PMID:
5035782
28.

Delay of erythema of human skin by anti-inflammatory drugs after ultraviolet irradiation.

Gruber CM Jr, Ridolfo AS, Nickander R, Mikulaschek WM.

Clin Pharmacol Ther. 1972 Jan-Feb;13(1):109-13. No abstract available.

PMID:
5008187
29.

Antipyretic effect of fenoprofen.

Gruber CM Jr, Collins T.

J Med. 1972;3(4):242-8. No abstract available.

PMID:
4564693
30.
31.

Physiological disposition of fenoprofen in man. I. Pharmacokinetic comparison of calcium and sodium salts administered orally.

Rubin A, Rodda BE, Warrick P, Ridolfo A, Gruber CM.

J Pharm Sci. 1971 Dec;60(12):1797-801. No abstract available.

PMID:
5157992
32.

Concentration of propoxyphene in human plasma following repeated oral doses.

Wolen RL, Gruber CM Jr, Kiplinger GF, Scholz NE.

Toxicol Appl Pharmacol. 1971 Jul;19(3):493-7. No abstract available.

PMID:
5571352
33.

Relief of postpartum uterine cramping with propoxyphene and aspirin.

Gruber CM Jr, Baptisti A Jr, Kiplinger GF.

Toxicol Appl Pharmacol. 1971 Jul;19(3):546-53. No abstract available.

PMID:
5106309
34.

The concentration of propoxyphene in the plasma and analgesia scores in postpartum patients.

Wolen RL, Gruber CM Jr, Baptisti A Jr, Scholz NE.

Toxicol Appl Pharmacol. 1971 Jul;19(3):498-503. No abstract available.

PMID:
5106308
35.

Evaluation of plasma concentrations of propoxyphene utilizing a hybrid principal component-analysis of variance technique. Case II--equipotent doses.

Rodda BE, Scholz NE, Gruber CM Jr, Wolen RL.

Toxicol Appl Pharmacol. 1971 Jul;19(3):563-71. No abstract available.

PMID:
4937003
36.

Evaluation of plasma concentrations of propoxyphene utilizing a hybrid principal component-analysis of variance technique. Case 1--equimolar doses.

Rodda BE, Scholz NE, Gruber CM Jr, Wolen RL.

Toxicol Appl Pharmacol. 1971 Jul;19(3):554-62. No abstract available.

PMID:
4937002
37.

A comparative study of the effects of chronic administration of propoxyphene salts to normal volunteers.

Kiplinger GF, Gruber CM Jr, Pierce EC.

Toxicol Appl Pharmacol. 1971 Jul;19(3):528-36. No abstract available.

PMID:
4937001
38.

The effectiveness and side-effect liability of propoxyphene hydrochloride and propoxyphene napsylate in patients with postpartum uterine cramping.

Baptisti A Jr, Gruber CM Jr, Santos EL.

Toxicol Appl Pharmacol. 1971 Jul;19(3):519-27. No abstract available.

PMID:
4937000
39.

Analgesia scores as timed responses following oral administration of propoxyphene to postpartum patients.

Gruber CM Jr, Wolen RL, Baptisti A Jr.

Toxicol Appl Pharmacol. 1971 Jul;19(3):504-11. No abstract available.

PMID:
4936998
40.

Concentration of propoxyphene in human plasma following oral, intramuscular, and intravenous administration.

Wolen RL, Gruber CM Jr, Kiplinger GF, Scholz NE.

Toxicol Appl Pharmacol. 1971 Jul;19(3):480-92. No abstract available.

PMID:
4936997
41.

Propoxyphene napsylate: chemistry and experimental design.

Gruber CM Jr, Stephens VC, Terrill PM.

Toxicol Appl Pharmacol. 1971 Jul;19(3):423-6. No abstract available.

PMID:
4936996
42.

Determination of propoxyphene in human plasma by gas chromatography.

Wolen RL, Gruber CM Jr.

Anal Chem. 1968 Jul;40(8):1243-6. No abstract available.

PMID:
5743277
43.

The use of non-narcotic analgesic drugs in postpartum patients.

Baptisti A Jr, Chernish SM, Gruber CM Jr.

Arch Int Pharmacodyn Ther. 1966 Jan;159(1):234-9. No abstract available.

PMID:
5918763
44.

Estimating the acceptability of morphine and noracymethadol in postpartum patients.

GRUBER CM Jr, BAPTISTI A Jr.

Clin Pharmacol Ther. 1963 Mar-Apr;4:172-81. No abstract available.

PMID:
13950878
45.

A secondary amine producing analgesia in humans.

STOELTING VK, GRUBER CM Jr, WALTON G.

Appl Ther. 1963 Feb;5:129-32. No abstract available.

PMID:
13984248
46.

Comparative evaluation of analgesic agents in postpartum patients: oral dextropropoxyphene, codeine, and meperidine.

GRUBER CM Jr, BAPTISTI A Jr, CHERNISH SM.

Anesth Analg. 1962 Sep-Oct;41:538-44. No abstract available.

PMID:
13902355
47.

Comparison of analgesic and side effects of parenteral dpropoxyphene and meperidine.

STOELTING VK, STOELTING RK, GRUBER CM Jr.

Anesthesiology. 1962 Jan-Feb;23:21-6. No abstract available.

PMID:
13917321
48.
49.

[Evaluation of an antitussive drug].

GRUBER CM Jr, CARTER CH, CHERNISH SM, EPSTEIN IL, KILLINGER RR, LARGAESPADA M, PRIEBE F, RAFALSKI TA, SPARKMAN DR.

J Indiana State Med Assoc. 1961 Nov;54:1643-6. Czech. No abstract available.

PMID:
13902357
50.

A measure of the effectiveness of propoxyphene antitussives in children.

GRUBER CM Jr, CARTER CH.

Am J Med Sci. 1961 Oct;242:443-7. No abstract available.

PMID:
13902358

Supplemental Content

Loading ...
Support Center